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In recent years, certain Pharmaceutical-Like remedies with their appearance 
changed, have been sold to the public through distribution by retail pharmacy, 
supermarkets and Internet as a result of untrue advertisement.  They are 
potentially dangerous to the public health. Such distribution disrupts the 
pharmaceutical market order and made an impact on the government credibility. 
This article, by following both of the comparative study and systematic analysis 
methodologies, outlines and draws the path of regulation policies. Based on the 
vertical comparison between the present legal system of regulating 
pharmaceutical-like remedies on the state level and on the provincial level in 
China as well as the horizontal comparison on important legal terms in respect of 
pharmaceuticals control in China and in overseas main countries, existing issues 
for administration of pharmaceutical-like remedies are indicated; advice and 
solutions on improvements of regulating pharmaceutical-like remedies in China 
have been proposed.   
This article includes three parts, i.e., the preface, main body and conclusion. 
The main body contains three chapters. 
The first chapter contains general description of the pharmaceutical-like 
remedies and describes the necessities to regulate the same. In this chapter, terms 
of pharmaceuticals and pharmaceutical-like remedies are interpreted and defined; 
types and features, developments and existing risks of pharmaceutical-like 
remedies in China are presented. The author believes that it is highly necessary to 
strengthen the regulation of pharmaceutical-like remedies, regardless of legal 
theory on protecting human rights, justice, freedom and equality, or practice 
theory on observing the principle of good faith, protecting legal interests of 
consumers, maintaining healthy development of pharmaceutical markets and 
government credibility. 
The second chapter describes the present status of regulating   
pharmaceutical-like remedies in China and its existing issues.  In this chapter, 
regulation status of pharmaceutical-like remedies is analyzed in the following  














methods.  Accordingly, the regulating issues includes but not limited to the 
following are indicated therein: legal system of regulating the pharmaceuticals 
shall be improved further; administrative approvals are confusing; multiple 
supervision results in both overlap and gap of regulation; and implementation is 
difficult. 
The third chapter describes the improvement on regulation of   
pharmaceutical-like remedies in China. In this chapter, methods on improving 
regulation systems in connection with pharmaceutical-like remedies are 
discussed in the following four respects: establishing legal system of 
pharmaceutical-like remedies, improvement of administrative licenses and 
supervision system, rationalization of supervision system. Moreover, solutions on 
improving implementation of regulation system regarding pharmaceutical-like 
remedies in China are proposed in the three respects below: exploring ways of 
control on online illegal activities concerning pharmaceuticals, workably 
increasing efficiency of administrative enforcement, realizing effective links 
between administrative enforcement and criminal procedures. 
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